CompletedPHASE2, PHASE3NCT00384449
Lucentis (Ranibizumab) for Eales' Disease
Studying Eales disease
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Oregon Health and Science University
- Principal Investigator
- Christina J. Flaxel, MD, MDCasey Eye Institute, Oregon Health & Science University
- Intervention
- Ranibizumab(drug)
- Enrollment
- 1 enrolled
- Eligibility
- 21 years · All sexes
- Timeline
- 2006 – 2009
Study locations (1)
- Casey Eye Institute, Portland, Oregon, United States
Collaborators
Genentech, Inc.
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00384449 on ClinicalTrials.gov